leadf
logo-loader
viewNaturally Splendid Enterprises Ltd.

Naturally Splendid Enterprises receives Health Canada authorization for COVID-19 trial

Naturally Splendid Enterprises announced that it has received a Notice of Authorization from Health Canada to proceed with a Phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug Cavaltinib.

Naturally Splendid Enterprises Ltd. -
Naturally Splendid Enterprises believes Cavaltinib will show the same positive results in mitigating the 'cytokine storm' with COVID-19 patients

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCQB:NSPDF) announced Tuesday that it has received a Notice of Authorization from Health Canada to proceed with a Phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug Cavaltinib.

Cavaltinib has been shown to inhibit cytokines, which are small proteins released by many different cells in the body, including those of the immune system where they coordinate the immune and inflammatory response against infection or other triggers. The company believes Cavaltinib will show the same positive results in mitigating the 'cytokine storm' with COVID-19 patients.

“This is of course a significant step forward in our pursuit of a COVID-19 treatment made even more important as we see additional waves of the virus continue to spread," Naturally Splendid CEO Craig Goodwin said in a statement. "The hope remains high that Cavaltinib will provide relief for those afflicted with COVID. We also anticipate the clinical trial to provide additional indications where Cavaltinib may be effective."

READ: Naturally Splendid tapping into rapidly growing plant-based food sector and is developing potential coronavirus treatment too

The Phase 2 clinical trial will be completed by the Plasm Pharmaceutical Inc (PLASM) team, a joint venture in which Naturally Splendid owns 16%. Naturally Splendid will receive a 10% royalty on gross sales of all PLASM products.

Naturally Splendid Enterprises also operates a Safe Quality Food Level 2 certified food manufacturing facility just outside Vancouver, British Columbia, owning recognized brands such as Natera Sport, Natera Hemp Foods, CHII, Elevate Me, and Woods Wild Bar. The company has developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp.

Shares in the company added 20% in Toronto on Tuesday to stand at C$0.060 each.

---Updates for share price---

Contact Sean at sean@proactiveinvestors.com

Quick facts: Naturally Splendid Enterprises Ltd.

Price: 0.065 CAD

TSX-V:NSP
Market: TSX-V
Market Cap: $13.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Naturally Splendid Enterprises Ltd. named herein, including the promotion by the Company of Naturally Splendid Enterprises Ltd. in any Content...

FOR OUR FULL DISCLAIMER CLICK HERE

Naturally Splendid adds another distributor for their plant-based food line...

Naturally Splendid (CVE: NSP- OTCQB: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive to bring news the company has found another distributor for their plant-based food product line called Natera. Goodwin telling Proactive Canadian based CANEX Foods which has been in operation since...

1 week, 4 days ago

2 min read